Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.
2.
3.

Structure-function relationships of complement receptor type 1.

Krych-Goldberg M, Atkinson JP.

Immunol Rev. 2001 Apr;180:112-22. Review.

PMID:
11414353
4.

Activation of the alternative complement pathway.

Fearon DT.

CRC Crit Rev Immunol. 1979 Nov;1(1):1-32. Review. No abstract available.

PMID:
162484
5.

[Alternative complement pathway].

Jouvin MH, Kazatchkine M.

Sem Hop. 1984 May 3;60(19):1371-8. Review. French.

PMID:
6326330
6.

[The alternative complement pathway].

Jouvin MH, Kazatchkine M.

Pathol Biol (Paris). 1983 Dec;31(10):839-46. Review. French.

PMID:
6230588
7.

Multiple ligand binding sites on domain seven of human complement factor H.

Giannakis E, Male DA, Ormsby RJ, Mold C, Jokiranta TS, Ranganathan S, Gordon DL.

Int Immunopharmacol. 2001 Mar;1(3):433-43. Review.

PMID:
11367528
8.

Structure/function of C5 convertases of complement.

Rawal N, Pangburn MK.

Int Immunopharmacol. 2001 Mar;1(3):415-22. Review.

PMID:
11367526
9.

Structural biology of the alternative pathway convertase.

Xu Y, Narayana SV, Volanakis JE.

Immunol Rev. 2001 Apr;180:123-35. Review.

PMID:
11414354
10.

Assembly and regulation of the complement amplification loop in blood: the role of C3b-C3b-IgG complexes.

Jelezarova E, Lutz HU.

Mol Immunol. 1999 Sep-Oct;36(13-14):837-42. Review.

PMID:
10698337
11.
12.

Regulation of complement activation by C-reactive protein.

Mold C, Gewurz H, Du Clos TW.

Immunopharmacology. 1999 May;42(1-3):23-30. Review.

PMID:
10408362
13.

Complement factor H-ligand interactions: self-association, multivalency and dissociation constants.

Perkins SJ, Nan R, Li K, Khan S, Miller A.

Immunobiology. 2012 Feb;217(2):281-97. doi: 10.1016/j.imbio.2011.10.003. Epub 2011 Oct 28. Review.

14.

Complement control protein factor H: the good, the bad, and the inadequate.

Ferreira VP, Pangburn MK, Cortés C.

Mol Immunol. 2010 Aug;47(13):2187-97. doi: 10.1016/j.molimm.2010.05.007. Review.

15.

C3 convertases of complement. Molecular genetics, structure and function of the catalytic domains, C2 and B.

Volanakis JE.

Year Immunol. 1989;4:218-30. Review. No abstract available.

PMID:
2648703
16.

Molecular biology and chemistry of the alternative pathway of complement.

Müller-Eberhard HJ, Schreiber RD.

Adv Immunol. 1980;29:1-53. Review. No abstract available.

PMID:
6158260
17.

Human complement regulators: a major target for pathogenic microorganisms.

Lindahl G, Sjöbring U, Johnsson E.

Curr Opin Immunol. 2000 Feb;12(1):44-51. Review.

PMID:
10679403
18.

[Activation of the alternative pathway of human complement (author's transl)].

Kazatchkine M, Fischer E, Nydegger U.

Ann Immunol (Paris). 1982 Mar-Apr;133C(2):181-8. Review. French.

PMID:
7051949
19.

The alternative pathway of complement.

Pangburn MK, Müller-Eberhard HJ.

Springer Semin Immunopathol. 1984;7(2-3):163-92. Review. No abstract available.

PMID:
6238433
20.

Evolutionary implications of a new bypass activation pathway of the complement system.

Farries TC, Steuer KL, Atkinson JP.

Immunol Today. 1990 Mar;11(3):78-80. Review.

PMID:
2186743

Supplemental Content

Support Center